Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primates

Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primates

<p><b>Abstract</b></p> <p><b>Background</b></p> <p>Adeno-associated vectors (rAAV) have been used to attain long-term liver gene expression. In humans, the cellular immune response poses a serious obstacle for transgene persistence while neutrali...

Full description

Bibliographic Details
Main Authors:	Unzu Carmen, Hervás-Stubbs Sandra, Sampedro Ana, Mauleón Itsaso, Mancheño Uxua, Alfaro Carlos, de Salamanca Rafael, Benito Alberto, Beattie Stuart G, Petry Harald, Prieto Jesús, Melero Ignacio, Fontanellas Antonio
Format:	Article
Language:	English
Published:	BMC 2012-06-01
Series:	Journal of Translational Medicine
Subjects:	Adeno-associated virus serotype 5 Neutralizing antibodies Re-administration Vector Immunology/Host Responses Immunomodulation
Online Access:	http://www.translational-medicine.com/content/10/1/122

Similar Items

Immunomodulation in Administration of rAAV: Preclinical and Clinical Adjuvant Pharmacotherapies
by: Wing Sum Chu, et al.
Published: (2021-04-01)

Tyrosine Mutation in AAV9 Capsid Improves Gene Transfer to the Mouse Lung
by: Sabrina V. Martini, et al.
Published: (2016-07-01)

rAAV8 and rAAV9-Mediated Long-Term Muscle Transduction with Tacrolimus (FK506) in Non-Human Primates
by: Akiko Ishii, et al.
Published: (2020-09-01)

Liver-Directed AAV8 Booster Vaccine Expressing Plasmodium falciparum Antigen Following Adenovirus Vaccine Priming Elicits Sterile Protection in a Murine Model
by: Mohammad Shahnaij, et al.
Published: (2021-06-01)

Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors
by: Qizhao Wang, et al.
Published: (2017-03-01)

Influence of rAAV DNA on its replication, encapsidation and infectivity
by: Savy, Adrien
Published: (2016)

AAV-S: A versatile capsid variant for transduction of mouse and primate inner ear
by: Maryna V. Ivanchenko, et al.
Published: (2021-06-01)

MSD-based assays facilitate a rapid and quantitative serostatus profiling for the presence of anti-AAV antibodies
by: Blazevic, D., et al.
Published: (2022)

Thermal Stability as a Determinant of AAV Serotype Identity
by: Antonette Bennett, et al.
Published: (2017-09-01)

Immune responses to AAV vectors, from bench to bedside
Published: (2015)

AAV9‐mediated AIRE gene delivery clears circulating antibodies and tissue T‐cell infiltration in a mouse model of autoimmune polyglandular syndrome type‐1
by: Sarah Almaghrabi, et al.
Published: (2020-01-01)

Biochemical and Structural studies of AAV-2 Rep68-AAVS1 complex assembly
by: Bishop, Clayton
Published: (2014)

Evading the AAV Immune Response in Mucopolysaccharidoses
by: Matthew Piechnik, et al.
Published: (2020-05-01)

Evaluation of AAV-DJ vector for retinal gene therapy
by: Yusaku Katada, et al.
Published: (2019-01-01)

Accurate Quantification of AAV Vector Genomes by Quantitative PCR
by: Cristina Martinez-Fernandez de la Camara, et al.
Published: (2021-04-01)

AAV9-NPC1 significantly ameliorates Purkinje cell death and behavioral abnormalities in mouse NPC disease
by: Chang Xie, et al.
Published: (2017-03-01)

Coagulation factor IX gene transfer to non-human primates using engineered AAV3 capsid and hepatic optimized expression cassette
by: Sandeep R.P. Kumar, et al.
Published: (2021-12-01)

Humoral immune response to AAV
by: Roberto eCalcedo, et al.
Published: (2013-10-01)

Immune responses to AAV vectors, the Glybera example from bench to bedside
by: Valerie eFerreira, et al.
Published: (2014-03-01)

Planet of the AAVs: The Spinal Cord Injury Episode
by: Katerina Stepankova, et al.
Published: (2021-05-01)

Design and engineering of capsid modified AAV-Based vectors targeted towards angiogenic and proliferating vasculature
by: Stachler, Matthew D.
Published: (2007)

Glial-derived neurotrophic factor gene transfer for Parkinson's disease: Anterograde distribution of AAV2 vectors in the primate brain
by: Adrian P. Kells, et al.
Published: (2012-11-01)

Cross-Packaging and Capsid Mosaic Formation in Multiplexed AAV Libraries
by: Pauline F. Schmit, et al.
Published: (2020-06-01)

Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?
by: Wei Zhan, et al.
Published: (2021-05-01)

Long-Term Metabolic Correction of Phenylketonuria by AAV-Delivered Phenylalanine Amino Lyase
by: Rui Tao, et al.
Published: (2020-12-01)

Immunological Monitoring to Rationally Guide AAV Gene Therapy
by: Cedrik Michael Britten, et al.
Published: (2013-09-01)

Preferred transduction with AAV8 and AAV9 via thalamic administration in the MPS IIIB model: A comparison of four rAAV serotypes
by: J.A. Gilkes, et al.
Published: (2016-03-01)

A Small Virus to Deliver Small Antibodies: New Targeted Therapies Based on AAV Delivery of Nanobodies
by: Noelia Silva-Pilipich, et al.
Published: (2021-09-01)

Preclinical Assessment of Immune Responses to AAV (adeno-associated virus) Vectors
by: Etiena eBasner-Tschakarjan, et al.
Published: (2014-02-01)

Adeno-Associated Virus Vectors (AAV) Expressing Phenylalanine Hydroxylase (PAH)
by: Ayşegül Akbay Yarpuzlu
Published: (2009-06-01)

Optimization of AAV vectors to target persistent viral reservoirs
by: Rossana Colón-Thillet, et al.
Published: (2021-04-01)

The Structure of an AAV5-AAVR Complex at 2.5 Å Resolution: Implications for Cellular Entry and Immune Neutralization of AAV Gene Therapy Vectors
by: Mark A. Silveria, et al.
Published: (2020-11-01)

Optimizing AAV2/6 microglial targeting identified enhanced efficiency in the photoreceptor degenerative environment
by: Margaret E. Maes, et al.
Published: (2021-12-01)

Cell-penetrating peptides enhance the transduction of adeno-associated virus serotype 9 in the central nervous system
by: Yuan Meng, et al.
Published: (2021-06-01)

Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors
by: Johanna Reul, et al.
Published: (2019-02-01)

AAV vector distribution in the mouse respiratory tract following four different methods of administration
by: Lisa A. Santry, et al.
Published: (2017-05-01)

Efficacious, safe, and stable inhibition of corneal neovascularization by AAV-vectored anti-VEGF therapeutics
by: Wenqi Su, et al.
Published: (2021-09-01)

Peripapillary Intravitreal Injection Improves AAV-Mediated Retinal Transduction
by: Sanjar Batirovich Madrakhimov, et al.
Published: (2020-06-01)

Immune Response Mechanisms against AAV Vectors in Animal Models
by: Ashley T. Martino, et al.
Published: (2020-06-01)

AAV Vectored Immunoprophylaxis for Filovirus Infections
by: Amira D. Rghei, et al.
Published: (2020-11-01)